Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancerRu M. Wen, James D. Brooks, Sharon J. Pitteri et al.|Journal of Clinical Investigation|2024Cited by 41
Abstract 4325: FXYD5 plays diverse roles in immune evasion and tumor progression in prostate cancerRu Wen, James D. Brooks, Sharon J. Pitteri et al.|Cancer Research|2025Cited by 1